The future of antibody drug discovery: From target validation to candidate selection
This webinar will provide an overview of the antibody discovery process highlighting the critical steps involved in developing effective antibody-based therapeutics.
In this webinar, you will learn how Benchling’s Antibody Solution Accelerator can support:
Target Identification: The crucial step of identifying and validating specific molecular targets that play a role in disease pathogenesis.
Lead Selection: Criteria and assays used to assess factors such as binding affinity, specificity, stability, and pharmacokinetic properties to choose the most suitable leads for further development.
In Vivo Safety & Efficacy: Assessing the performance of the antibody in mice and other model organisms.
And more!
